Long-term prognosis for 1-year relapse-free survivors of CD34 cell–selected allogeneic hematopoietic stem cell transplantation: a landmark analysis

CD34 selection significantly improves GVHD-free survival in allogeneic hematopoietic cell transplantation (allo-HSCT). Specific information regarding long-term prognosis and risk factors for late mortality after CD34-selected allo-HSCT is lacking, however. We conducted a single-center landmark analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Christina, Hsu, Meier, Barba, Pere, Maloy, Molly A., Avecilla, Scott T., Barker, Juliet N., Castro-Malaspina, Hugo, Giralt, Sergio A., Jakubowski, Ann A., Koehne, Guenther, Meagher, Richard C., O'Reilly, Richard J., Papadopoulos, Esperanza B., Ponce, Doris M., Tamari, Roni, van den Brink, Marcel R. M., Young, James W., Devlin, Sean M., Perales, Miguel-Angel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718946/
https://www.ncbi.nlm.nih.gov/pubmed/28991247
http://dx.doi.org/10.1038/bmt.2017.197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718946/
https://www.ncbi.nlm.nih.gov/pubmed/28991247
http://dx.doi.org/10.1038/bmt.2017.197

Ejemplares similares